The Montalcino Aortic Consortium (MAC) will provide the infrastructure to assemble large cohorts of patients with mutations in known heritable thoracic aortic disease (H-TAD) genes, define the phenotype associated with these genes, and determine genetic and environmental modifiers of H-TAD.
Aortic Aneurysm, Aortic Dissection, Aortic Diseases
The Montalcino Aortic Consortium (MAC) will provide the infrastructure to assemble large cohorts of patients with mutations in known heritable thoracic aortic disease (H-TAD) genes, define the phenotype associated with these genes, and determine genetic and environmental modifiers of H-TAD.
Montalcino Aortic Consortium: Precision Medicine for Heritable Thoracic Aortic Disease
-
The University of Texas Health Science Center at Houston, Houston, Texas, United States, 77030
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
to
ALL
Yes
The University of Texas Health Science Center, Houston,
Dianna Milewicz, MD, PhD, STUDY_DIRECTOR, UTHealth
2037-01-01